Open AccessBaclofen Induced Encephalopathy in Patients with Chronic Kidney Disease
Author(s) -
Alok Kumar,
Dorchhom Khrime,
N.K. Bansal,
Saurabh Agarwal,
Utkarsh Sharma
Publication year - 2020
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2020/44729.13998
Subject(s) - baclofen , medicine , kidney disease , encephalopathy , anesthesia , neurotoxicity , dialysis , ingestion , surgery , toxicity , receptor , agonist
Hiccups are manifestation of uremic syndrome. Baclofen had been used in uremic hiccups, but its usage has been described in literature with development of neurotoxicity in patients with renal failure. The case series reports three patients of Chronic Kidney Disease (CKD) that were on haemodialysis. All of them had intractable hiccups, for which Baclofen was administered. They developed encephalopathy within 24-48 hours of ingestion of Baclofen. The drug was discontinued and the patients improved within 36-48 hours. They were finally discharged with no residual neurological deficit.